Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.

Saved in:
Bibliographic Details
Title: Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.
Authors: Bode D; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Semmler L; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany., Wakula P; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany., Hegemann N; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany., Primessnig U; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Beindorff N; Berlin Experimental Radionuclide Imaging Center (BERIC), Charité-Universitaetsmedizin Berlin, Berlin, Germany., Powell D; Lexicon Pharmaceuticals, Metabolism Research, Houston, TX, USA., Dahmen R; Sanofi-Aventis Deutschland GmbH, Research & Development, 65926, Frankfurt am Main, Germany., Ruetten H; Sanofi-Aventis Deutschland GmbH, Research & Development, 65926, Frankfurt am Main, Germany., Oeing C; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Alogna A; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Messroghli D; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Department of Internal Medicine and Cardiology, German Heart Center Berlin, 13353, Berlin, Germany., Pieske BM; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Department of Internal Medicine and Cardiology, German Heart Center Berlin, 13353, Berlin, Germany., Heinzel FR; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany., Hohendanner F; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany. felix.hohendanner@charite.de.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany. felix.hohendanner@charite.de.; Berlin Institute of Health (BIH), Berlin, Germany. felix.hohendanner@charite.de.
Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2021 Jan 07; Vol. 20 (1), pp. 7. Date of Electronic Publication: 2021 Jan 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first